Prenetics Global Limited (NASDAQ:PRE) is one of the 7 Fastest Growing Asian Stocks to Buy.
On March 24, 2026, Prenetics Global Limited (NASDAQ:PRE) announced a strategic partnership with Superpower to combine clinical-grade supplementation with blood diagnostics. The company said the collaboration integrates testing and supplementation into a unified system, allowing consumers to measure supplement effectiveness, with IM8 incorporating Superpower’s testing membership and Superpower featuring IM8 products in its protocols.
On March 16, 2026, Lake Street initiated coverage on Prenetics Global Limited (NASDAQ:PRE) with a Buy rating and a $29 price target, citing the company’s shift to a focused consumer health platform after divesting non-core assets and generating over $150M in proceeds.
Prenetics Global (PRE) Partners with Superpower on Diagnostics and Supplements
Africa Studio/Shutterstock.com
Earlier in March, the company authorized a $40M share repurchase program over 12 months, with Chief Executive Officer Danny Yeung saying the move reflects confidence in the business and its IM8 brand trajectory, alongside a strong liquidity position and no debt.
Prenetics Global Limited (NASDAQ:PRE) operates a consumer health platform focused on wellness products and services globally.
While we acknowledge the potential of PRE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Follow Insider Monkey on Google News.
